Clinical Trial Research
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
Published in Blood Weekly, March 13th, 2008
Synthetic Blood International, Inc. (OTCBB:SYBD) announced that The United States Department of Defense (DoD) has approved the award of a $1.9 million grant to M. Ross Bullock, M.D., Ph.D., of the University of Miami Miller School of Medicine, Department of Neurosurgery and principal investigator for the Company's planned Phase IIb clinical trial with Oxycyte(TM) for the treatment of traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute.
"With this grant, we will be able to double our planned enrollment in the Phase IIb trial to 200 TBI patients, providing a larger statistical basis for evaluating...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-03-13)
More Articles from Blood Weekly
- Coagulation
Scripps scientists studying sepsis in mice find potential drug targets for deadly disease - Sepsis
Researchers find possible target to treat deadly bloodstream infections - Breast Cancer
New breast cancer data have been reported by researchers at Herlev University - Cochleate Cylinders
Research from State University of New York broadens understanding of cochleate cylinders - Dengue Fever
New findings reported from R.M.R. Nogueira and co-authors describe advances in dengue fever - Electron Microscopy
Data on electron microscopy described by researchers at Johann Wolfgang Goethe University - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
